Northern blot analysis of acn, citZ, and icd. (A) Samples of total RNA were prepared from cells in early exponential growth phase (lane 1, untreated), after 30 min in pH 5.5 (lane 2), in 400 mM NaCl (lane 3), and with 1/10 vol of plasma (lane 4). The hybridization was achieved with the 32P-labeled probe deduced from AR-186 (probe a), with the sequence complementary to the 5′ end of acn. (B) Samples of total RNA were prepared from cells in early exponential growth phase (lane 1, untreated), after 30 min in pH 5.5 (lane 2), in 400 mM NaCl (lane 3), and after incubation at 42°C and in 1/10 vol of plasma (lane 4) or serum (lane 5). The hybridization was achieved with the 32P-labeled probe deduced from AR-731 (probe b), with a sequence complementary to both citZ and icd. (C) Total RNA from S. mutans GS-5 cells without treatment (control, lane 1) or treated with pH 5.5 (lane 2), with 400 mM NaCl (lane 3) and at 42°C (lane 4), and with 1/10 vol of plasma (lane 5) for 30 min was hybridized with radiolabeled probe c, with a sequence complementary to the 5′ end of icd. (D) Schematic representation of the S. mutans chromosome containing the genes acn, citZ, and icd, involved in the citrate pathway. The small black bars under the cluster indicate positions of the different probes used for Northern blots. Arrows indicate positions of the predicted transcripts, m1 (acn) and m2 (citZ-icd operon). The m3 might correspond to the transcript of icd only or might be a processed product of m2.